Hideji Masuoka
- Oncology top 10%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Pathology and Forensic Medicine
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Seigo NakamuraTakayuki IwamotoKotaro IijimaTakayuki KinoshitaNaoki NiikuraShinobu MasudaNaoki HayashiYutaka Tokuda
- Topics
- Breast Cancer Treatment Studies (12 papers)Cancer Treatment and Pharmacology (5 papers)Breast Lesions and Carcinomas (4 papers)
- Partner nations
- JapanSwitzerlandUnited States
In The Last Decade
Hideji Masuoka
19 papers receiving 337 citations
Peers
Comparison fields: 5 of 49
- Oncology 239
- Cancer Research 189
- Pulmonary and Respiratory Medicine 85
- Pathology and Forensic Medicine 74
- Radiology, Nuclear Medicine and Imaging 65
Countries citing papers authored by Hideji Masuoka
This map shows the geographic impact of Hideji Masuoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideji Masuoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideji Masuoka more than expected).
Fields of papers citing papers by Hideji Masuoka
This network shows the impact of papers produced by Hideji Masuoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideji Masuoka. The network helps show where Hideji Masuoka may publish in the future.
Co-authorship network of co-authors of Hideji Masuoka
This figure shows the co-authorship network connecting the top 25 collaborators of Hideji Masuoka. A scholar is included among the top collaborators of Hideji Masuoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideji Masuoka. Hideji Masuoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 18 | |
| 3 | 9 | |
| 4 | 2 | |
| 5 | 19 | |
| 6 | 56 | |
| 7 | 45 | |
| 8 | 131 | |
| 9 | 8 | |
| 10 | 5 | |
| 11 | 5 | |
| 12 | 2 | |
| 13 | 2 | |
| 14 | 2 | |
| 15 | 3 | |
| 16 | 0 | |
| 17 | [Assessment of post-administration body distribution of toremifene and tamoxifen, and their administration regimens]. | 1 |
| 18 | 0 | |
| 19 | 5 | |
| 20 | 7 |
About Hideji Masuoka
Hideji Masuoka is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 23 papers that have together received 346 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (5 papers) and Breast Lesions and Carcinomas (4 papers). The work is most often cited by research in Cancer Research (189 citations), Oncology (239 citations) and Pathology and Forensic Medicine (74 citations). Hideji Masuoka has collaborated with scholars based in Japan, Switzerland and United States. Frequent co-authors include Seigo Nakamura, Takayuki Iwamoto, Kotaro Iijima, Takayuki Kinoshita, Naoki Niikura, Shinobu Masuda, Naoki Hayashi, Yutaka Tokuda, Masaaki Kawai and Koichiro Tsugawa. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.